Together, these data suggest that STK25 abrogation confers resistance to hepatocyte apoptosis induced by DEN or CDAA challenge, and suppresses HCC development through attenuated tumor cell proliferation and angiogenesis. Here, STK25 is linked to hepatocellular carcinoma.